Scientific Sessions 2024  /  Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?  /  Discussant: SUMMIT CMR
Logo

American Heart Association

  2
  0

Final ID:

Discussant: SUMMIT CMR

  • Kramer, Chris  ( CCHMC , Cincinnati , Ohio , United States )
  • Rider, Oliver  ( CCHMC , Cincinnati , Ohio , United States )
  • Wilcox, Jane  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
    • Author Disclosures:
    Chris Kramer: No Answer | Oliver Rider: DO NOT have relevant financial relationships | Jane Wilcox: DO have relevant financial relationships ; Advisor:Abiomed:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Speaker:Boehringer Ingelheim:Active (exists now) ; Consultant:Abbott:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Incretin Modulation: Is a New Standard of Care Emerging?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Effects of Tirzepatide on the Clinical and Symptom Burden of Patients with Heart Failure and a Preserved Ejection Fraction, Results from the SUMMIT Trial

Zile Michael

Discussant: SUMMIT

Lewis Eldrin

More abstracts from these authors:
Lost to Follow Up: A Rare Case of Malonyl-CoA Decarboxylase Deficiency Induced Cardiomyopathy in an Adult Spanish Speaking Hispanic Male

Iniguez Reniell, Quaggin-smith Jessica, Hale Sarah, Wilcox Jane

High Frequency of Ejection Fraction Decline in Patients with Heart Failure with Improved Ejection Fraction

Pensa Anthony, Davis Lucia, Wu Tingqing, Zheng Veronica, Harap Rebecca, Wilcox Jane

You have to be authorized to contact abstract author. Please, Login
Not Available